Professional Documents
Culture Documents
Approach To Managing Hiccups in A Cancer Patient
Approach To Managing Hiccups in A Cancer Patient
Page 1 of 3
Released Date: May 2021
National Cancer Grid
NCG Palliative Care Guidelines - Hiccups
H2-receptor antagonist
Ranitidine 150 mg twice /Day. Reduce to
once /Day if renal impairement
Haloperidol 0.5-1mg TDS. Baclofen 5mg - May Low dose intravenous Gabapentin as burst Nifedipine 5-20mg TDS
Maintenance dose 1mg to be titrated up not > lignocaine infusion not with 400 TDS X 3 P.O or sublingually
3mg at bedtime. 20mg / day. > 2-4mg / kg and days (caution- hypotensive)
Olanzapine 2.5-5 mg OD Caution in elderly administered slowly and titrate down to
Chlorpromazine- 10-25 mg – and patients with over 45 -60 minutes. 400mg OD and then
titrate if required upto 25-50 renal dysfunction stop
mg TDS Or - nebulisation (consider Sodium Valproate –
Methylphenidate 5 mg OD – aspiration risk) 200-500 mg P.O
in sedated patients on opioid 15mg/kg/24 hours in
– Max- 5-10 mg BD divided doses
1
Palliative Care Formulary 5th edition – Robert Twycross
Page 2 of 3
Released Date: May 2021
National Cancer Grid
NCG Palliative Care Guidelines - Hiccups
Initial treatment for persistent hiccups should be reviewed after 3 days and changed if there is little or no improvement. This may mean a dose increase
or a change of medication.
Supportive Care
Page 3 of 3
Released Date: May 2021
National Cancer Grid